共 830 条
[1]
Denkert C(2017)Molecular alterations in triple-negative breast cancer - the road to new treatment strategies Lancet 389 2430-2442
[2]
Liedtke C(2019)The neoepitope landscape of breast cancer: implications for immunotherapy BMC Cancer 19 200-238
[3]
Tutt A(2015)Classical pathology and mutational load of breast cancer - integration of two worlds J Pathol Clin Res 1 225-250
[4]
von Minckwitz G(2016)The genomic landscape of breast cancer and its interaction with host immunity Breast 29 241-206
[5]
Narang P(2019)Tumor mutational load predicts survival after immunotherapy across multiple cancer types Nat Genet 51 202-2608
[6]
Chen M(2017)Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Molecular Cancer Therapeutics 16 2598-1550
[7]
Sharma AA(2014)Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial Ann Oncol 25 1544-271
[8]
Anderson KS(2015)The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Ann Oncol 26 259-50
[9]
Wilson MA(2018)Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy Lancet Oncol 19 40-1360
[10]
Budczies J(2016)Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review JAMA Oncology. 2 1354-34